Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim Fox

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
European Heart Journal|June 12, 2010
Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery diseaseJasper Jan Brugts, Aaron Isaacs, Eric Boersma, et al.
Journal of the American College of Cardiology|May 14, 2021
Diabetes-Related Factors and the Effects of Ticagrelor Plus Aspirin in the THEMIS and THEMIS-PCI TrialsLawrence A Leiter, Deepak L Bhatt, Darren K McGuire, et al.
The New England Journal of Medicine|September 3, 2019
Ticagrelor in Patients with Stable Coronary Disease and DiabetesP Gabriel Steg, Deepak L Bhatt, Tabassome Simon, et al.
International Journal of Cardiology|October 21, 2022
External applicability of the Effect of ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) trial: An analysis of patients with diabetes and coronary artery disease in the REduction of Atherothrombosis for Continued Health (REACH) registryJeremie Abtan, Deepak L Bhatt, Yedid Elbez, et al.
Lancet (London, England)|September 6, 2019
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trialDeepak L Bhatt, Philippe Gabriel Steg, Shamir R Mehta, et al.
Journal of Hypertension|December 16, 2010
A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individualsJasper J Brugts, Aaron Isaacs, Moniek Pm de Maat, et al.
European Heart Journal|July 16, 2021
Fractional flow reserve derived from computed tomography coronary angiography in the assessment and management of stable chest pain: the FORECAST randomized trialNick Curzen, Zoe Nicholas, Beth Stuart, et al.
BMJ Open|May 20, 2018
Determining the pneumococcal conjugate vaccine coverage required for indirect protection against vaccine-type pneumococcal carriage in low and middle-income countries: a protocol for a prospective observational studyJocelyn Chan, Cattram D Nguyen, Jana Y R Lai, et al.
Circulation. Genomic and Precision Medicine|March 22, 2019
Subsequent Event Risk in Individuals With Established Coronary Heart DiseaseRiyaz S Patel, Vinicius Tragante, Amand F Schmidt, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
European Heart Journal|June 12, 2010
Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery diseaseJasper Jan Brugts, Aaron Isaacs, Eric Boersma, et al.
Journal of the American College of Cardiology|May 14, 2021
Diabetes-Related Factors and the Effects of Ticagrelor Plus Aspirin in the THEMIS and THEMIS-PCI TrialsLawrence A Leiter, Deepak L Bhatt, Darren K McGuire, et al.
The New England Journal of Medicine|September 3, 2019
Ticagrelor in Patients with Stable Coronary Disease and DiabetesP Gabriel Steg, Deepak L Bhatt, Tabassome Simon, et al.
International Journal of Cardiology|October 21, 2022
External applicability of the Effect of ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) trial: An analysis of patients with diabetes and coronary artery disease in the REduction of Atherothrombosis for Continued Health (REACH) registryJeremie Abtan, Deepak L Bhatt, Yedid Elbez, et al.
Lancet (London, England)|September 6, 2019
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trialDeepak L Bhatt, Philippe Gabriel Steg, Shamir R Mehta, et al.
Journal of Hypertension|December 16, 2010
A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individualsJasper J Brugts, Aaron Isaacs, Moniek Pm de Maat, et al.
European Heart Journal|July 16, 2021
Fractional flow reserve derived from computed tomography coronary angiography in the assessment and management of stable chest pain: the FORECAST randomized trialNick Curzen, Zoe Nicholas, Beth Stuart, et al.
BMJ Open|May 20, 2018
Determining the pneumococcal conjugate vaccine coverage required for indirect protection against vaccine-type pneumococcal carriage in low and middle-income countries: a protocol for a prospective observational studyJocelyn Chan, Cattram D Nguyen, Jana Y R Lai, et al.
Circulation. Genomic and Precision Medicine|March 22, 2019
Subsequent Event Risk in Individuals With Established Coronary Heart DiseaseRiyaz S Patel, Vinicius Tragante, Amand F Schmidt, et al.
Pageof 7